Hologic Announces Financial Results for Fourth Quarter of Fiscal 2024
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Hologic (HOLX) Reports In-Line Q4 EPS, Beats on Revenue; Offers Q1 EPS Guidance
November 4, 2024 4:05 PM ESTHologic (NASDAQ: HOLX) reported Q4 EPS of $1.01, in-line with the analyst estimate of $1.01. Revenue for the quarter came in at $987.9 million versus the consensus estimate of $978.27 million.
GUIDANCE:
Hologic sees Q1 2025 EPS of $1.00-$1.03, versus the consensus of $1.03.
For earnings history and earnings-related data on Hologic (HOLX) click here.
... More